Brand
PACIRA PHARMACEUTICALS INC
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for PACIRA PHARMACEUTICALS INC and translate it into plain English — free weekly digest, optional same-day alerts.
- 2024-07-03FDA-DrugClass IIZilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65250-001-01 (vial) with Diluent 5 mL Sterile single-use vial, Rx Only, Mfd. for: Pacira Pharmaceuticals, Inc. NDC 65250-002-01
Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C
- 2024-06-19FDA-DrugClass IIDrug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01. Carton Label: Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceut
Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
Get notified about new PACIRA PHARMACEUTICALS INC recalls
Free weekly digest. We email when a new federal recall affects PACIRA PHARMACEUTICALS INC or anything else in your household.
Get the Sunday Brief